Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age70-110
SponsorOregon Health and Science University

About this trial

Traditionally, general anesthesia is maintained with inhalational anesthesia (GAS), but there is a gap in knowledge regarding whether intravenous anesthesia (IV) can prevent deleterious postoperative outcomes in the geriatric surgical population. The goal of this clinical trial is to determine whether intravenous anesthesia (IV) leads to a decreased incidence of postoperative delirium (POD), postoperative cognitive dysfunction (POCD), and functional decline, and improved patient-reported outcomes (PROs) in older adults undergoing non-cardiac surgery when compared to the standard inhalational anesthesia (GAS). This single-center, 1:1 randomized, double-blind (patient \& outcome assessor) clinical trial will compare inhalational vs. intravenous anesthesia on POD, POCD, functional status, patient-reported outcomes (PROs), and blood-based biomarkers in older patients undergoing elective, inpatient, non-cardiac surgery. Upon enrollment, 260 women and men ≥ 70 years undergoing elective noncardiac surgery under general anesthesia will be randomized to 2 groups: TIVA or GAS.

Eligibility criteria

Qualifiers

Men and women ≥ 70 years

Sufficient vision and hearing to complete all tests

Proficient in spoken and written English

Scheduled for elective, inpatient, noncardiac surgery, expected to last at least 120 minutes requiring general anesthesia

Disqualifiers

Urgent or emergent surgery

Diagnosed dementia (or MoCA<19)

History of Parkinson's disease, major psychiatric disease (Schizophrenia), or severe traumatic brain injury

Ongoing alcohol or substance abuse (per DSM V criteria)

Trial design

Treatments tested in this trial

  • Sevoflurane
  • Propofol

Treatment groups

260 Participants
are divided into 2 treatment groups